Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts

Clinical trial NCT02246738 · COMPLETED

Trial details

NCT number: NCT02246738
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Study type: OBSERVATIONAL

Urothelial Carcinoma of the Bladder

Start date: 2014-08-01
Primary completion: 2018-08-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.